2023
Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study
Sanft T, Harrigan M, McGowan C, Cartmel B, Zupa M, Li F, Ferrucci L, Puklin L, Cao A, Nguyen T, Neuhouser M, Hershman D, Basen-Engquist K, Jones B, Knobf T, Chagpar A, Silber A, Tanasijevic A, Ligibel J, Irwin M. Randomized Trial of Exercise and Nutrition on Chemotherapy Completion and Pathologic Complete Response in Women With Breast Cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis Study. Journal Of Clinical Oncology 2023, 41: 5285-5295. PMID: 37656930, PMCID: PMC10691793, DOI: 10.1200/jco.23.00871.Peer-Reviewed Original ResearchMeSH KeywordsBreast NeoplasmsDietExerciseFemaleHumansLife StyleNutritional StatusTriple Negative Breast NeoplasmsConceptsRelative dose intensityPathologic complete responseProportion of patientsBreast cancerNeoadjuvant chemotherapyChemotherapy completionComplete responseNutrition interventionsHigher pathologic complete responseHuman epidermal growth factor receptor 2Epidermal growth factor receptor 2Triple-negative breast cancerChemotherapy dose adjustmentsHome-based exerciseGrowth factor receptor 2Breast cancer outcomesEffects of exerciseFactor receptor 2Electronic medical recordsChi-square testUsual careDose intensityExercise interventionDose adjustmentRandomized trials
2021
Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial
Sanft T, Harrigan M, Cartmel B, Ferrucci LM, Li FY, McGowan C, Zupa M, Nguyen TH, Ligibel J, Neuhouser ML, Hershman DL, Basen-Engquist K, Jones B, Knobf T, Chagpar A, Silber A, Irwin ML. Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial. Contemporary Clinical Trials 2021, 109: 106508. PMID: 34274495, PMCID: PMC10424280, DOI: 10.1016/j.cct.2021.106508.Peer-Reviewed Original ResearchMeSH KeywordsBreast NeoplasmsDiet, HealthyExerciseFemaleHumansLife StyleQuality of LifeRandomized Controlled Trials as TopicConceptsChemotherapy completion rateTreatment-related side effectsPhysical activity guidelinesBreast cancerActivity guidelinesCancer survivorsSide effectsWorld Cancer Research FundUsual care control groupCompletion ratesEndocrine therapy adherenceCare control groupHealthy lifestyle interventionRandomized clinical trialsPatient reported outcomesPhysical activity interventionsBreast cancer treatmentAmerican Cancer SocietyBreast cancer prognosisCancer Research FundElectronic medical recordsOncology nutritionTreating oncologistSecondary endpointsChemotherapy session
2001
Is Variation in Quality of Mammographic Services Race Linked?
Jones B, Culler C, Kasl S, Calvocoressi L. Is Variation in Quality of Mammographic Services Race Linked? Journal Of Health Care For The Poor And Underserved 2001, 12: 113-126. PMID: 11217224, DOI: 10.1353/hpu.2010.0562.Peer-Reviewed Original Research
1997
Severe Obesity as an Explanatory Factor for the Black/White Difference in Stage at Diagnosis of Breast Cancer
Jones B, Kasl S, Curnen M, Owens P, Dubrow R. Severe Obesity as an Explanatory Factor for the Black/White Difference in Stage at Diagnosis of Breast Cancer. American Journal Of Epidemiology 1997, 146: 394-404. PMID: 9290499, DOI: 10.1093/oxfordjournals.aje.a009292.Peer-Reviewed Original ResearchConceptsSevere obesityBreast cancerWhite womenRacial differencesBlack womenTNM stage IIPrevalence of obesityLogistic regression modelsObserved racial differencesBlack/White DifferencesRetrospective studyOdds ratioHigh prevalenceObesityStage IICancerDiagnosisWomenWhite differencesPrevalenceRegression modelsDifferencesLater stagesDiseaseImportant roleTime trend of female breast carcinoma In Situ by race and histology in Connecticut, U.S.A.
Zheng T, Holford T, Chen Y, Jones B, Flannery J, Boyle P. Time trend of female breast carcinoma In Situ by race and histology in Connecticut, U.S.A. European Journal Of Cancer 1997, 33: 96-100. PMID: 9071907, DOI: 10.1016/s0959-8049(96)00371-1.Peer-Reviewed Original ResearchConceptsAge-adjusted incidence ratesSitu breast cancerFemale breast carcinomaIncidence rateBreast cancerMammography screeningBreast carcinomaOverall age-adjusted incidence rateAge group 40 yearsAge groupsEarly-stage breast cancerAge-specific incidence ratesFemale breast cancer incidenceConnecticut Tumor RegistryBreast cancer incidenceStage breast cancerEfficacy of mammographyFemale breast cancerAge group 40Older age groupsTime trendsTumor RegistryIncident casesDuctal carcinomaCancer incidence
1995
Can mammography screening explain the race difference in stage at diagnosis of breast cancer?
Jones B, Kasl S, Curnen M, Owens P, Dubrow R. Can mammography screening explain the race difference in stage at diagnosis of breast cancer? Cancer 1995, 75: 2103-2113. PMID: 7697601, DOI: 10.1002/1097-0142(19950415)75:8<2103::aid-cncr2820750813>3.0.co;2-2.Peer-Reviewed Original ResearchConceptsBreast cancerWhite womenMammography screeningLate-stage diagnosisPopulation-based dataDevelopment of symptomsLate-stage cancerBlack womenAfrican American womenRace differencesRace-specific analysesScreening historyObserved race differencesRetrospective studyMammographic screeningActive surveillanceConnecticut hospitalsStage cancerCancerDiagnosisSocioeconomic statusWomenStage diagnosisSignificant predictorsAmerican women